📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults (2024)

First Author: Silman D

Attributed to: Dissecting the molecular basis for gamete recognition in the malaria parasite, and its targeting to block transmission funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.22900.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.22900.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research